Treatment outcomes for unresectable intrahepatic cholangiocarcinoma: Nationwide, population-based, cohort study based on propensity score matching with the Mahalanobis metric.

CONCLUSIONS: Definitive CCRT is the optimal therapy for patients with unresectable ICC without distant metastasis. PMID: 30279046 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30279046?dopt=Abstract

Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - September 29, 2018 Category: Radiology Authors: Chang WW, Hsiao PK, Qin L, Chang CL, Chow JM, Wu SY Tags: Radiother Oncol Source Type: research